Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients.
Reggiani Bonetti L, Migaldi M, Caredda E, Boninsegna A, Ponz De Leon M, Di Gregorio C, Barresi V, Scannone D, Danese S, Cittadini A, Sgambato A.
Reggiani Bonetti L, et al. Among authors: migaldi m.
Scand J Gastroenterol. 2012 Oct;47(10):1211-7. doi: 10.3109/00365521.2012.694904. Epub 2012 Aug 3.
Scand J Gastroenterol. 2012.
PMID: 22856425
Free article.